Navigation Links
Some Cancer Trials Overstate Findings, Analysis Claims
Date:3/25/2008

Group-randomized research sometimes uses inappropriate statistical analysis of a prevention effort

TUESDAY, March 25 (HealthDay News) -- The effectiveness of public campaigns or efforts to prevent cancer can often be overstated in certain kinds of cancer trials because of inappropriate statistical analysis, a new report claims.

The review, published in the March 25 online issue of the Journal of the National Cancer Institute, suggests that some of the 75 group-randomized cancer trials it studied may have reported these interventions were effective when in fact they might not have been.

"We cannot say any specific studies are wrong. We can say that the analysis used in many of the papers suggests that some of them probably were overstating the significance of their findings," review author David Murray, chairman of epidemiology in the College of Public Health at Ohio State University, said in a prepared statement.

In the review, more than a third of the 75 trials contained statistical analyses that the reviewers considered inappropriate to assess the intervention being studied. Most of those studies reported statistically significant intervention effects that, because of analysis flaws, could be misleading to scientists and policymakers, the review authors stated.

"If researchers use the wrong methods, and claim an approach was effective, other people will start using that approach. And if it really wasn't effective, then they're wasting time, money and resources and going down a path that they shouldn't be going down," Murray said.

In group-randomized trials, researchers randomly assign identifiable groups to specific conditions and observe outcomes for members of those groups to assess the effects of an intervention under study.

For example, a group-randomized trial might study the use of mass media to promote cancer screenings and then assess how many screenings result among groups that receive different kinds of messages.

The review is not an indictment of the study design. Murray is a proponent of such trials, and authored a 1998 textbook on the subject, "Design and Analysis of Group-Randomized Trials."

"We're not trying to discourage people from using this design. It remains the best design available if you have an intervention that can't be studied at the individual level," he said.

In analyzing the outcomes of such trials, researchers should take into account any similarities among group members or any common influences affecting the members of the same group, Murray said. However, the review found that the common ground among group members was often not factored into the final statistical analysis.

"In science, generally, we allow for being wrong 5 percent of the time. If you use the wrong analysis methods with this kind of study, you might be wrong half the time. We're not going to advance science if we're wrong half the time," said Murray, who is also a member of the Cancer Control Program in Ohio State's Comprehensive Cancer Center.

The review identified 75 articles published in 41 journals that reported intervention results based on group-randomized trials related to cancer or cancer risk factors from 2002 to 2006. Thirty-four of the articles, or 45 percent, reported the use of appropriate methods to analyze the results. Twenty-six articles, or 35 percent, reported only inappropriate methods used in the statistical analysis. Eight percent of the articles used a combination of appropriate and inappropriate methods, and nine articles had insufficient information to even judge whether the analytic methods were appropriate or not.

The use of inappropriate analysis methods is not considered willful or in any way designed to skew results of a trial, Murray noted.

Murray and his colleagues call for investigators to collaborate with statisticians familiar with group-randomized study methods, and for funding agencies and journal editors to ensure that such studies show evidence of proper design planning and data analysis.

More information

The American Cancer Society has more about prevention and early detection of cancer.



-- Kevin McKeever



SOURCE: Ohio State University, news release, March 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Cancer Trials Overstate Findings, Analysis Claims
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: